title: Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
authors.forename: E
authors.initials: E
authors.lastname: Arbustini
authors.forename: B
authors.initials: B
authors.lastname: Dal Bello
authors.forename: M
authors.initials: M
authors.lastname: Rinaldi
authors.forename: M
authors.initials: M
authors.lastname: Diegoli
authors.forename: M
authors.initials: M
authors.lastname: Grasso
authors.forename: C
authors.initials: C
authors.lastname: Pellegrini
authors.forename: P
authors.initials: P
authors.lastname: Morbini
authors.forename: L
authors.initials: L
authors.lastname: Martinelli
authors.forename: M R
authors.initials: MR
authors.lastname: Bonora
authors.forename: M
authors.initials: M
authors.lastname: Viganò
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D004699:Endocardium / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000473:pathology*; D016027:Heart Transplantation / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000473:pathology*; D009206:Myocardium / Q000473:pathology; D009894:Opportunistic Infections / Q000473:pathology*; D011446:Prospective Studies; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus